Key result
Pulmonary embolism is a frequent and serious complication in patients with lung cancer that significantly worsens prognosis and complicates anti-tumor therapy due to competing risks of thrombosis and hemorrhage.
Why the study?
Pulmonary embolism has a notably high incidence in individuals with lung cancer and significantly impacts prognosis and quality of life, making timely diagnosis and intervention of paramount importance.
Pulmonary embolism is a frequent complication in lung cancer that significantly reduces quality of life and worsens prognosis, necessitating timely diagnosis and intervention.
Warrants vigilance for PE in lung cancer; leaves open optimal prophylaxis strategies pending prospective trials.
Pulmonary embolism (PE), a form of venous thromboembolism, is a frequently observed complication in malignancies, with a notably high incidence in individuals with lung cancer. The presence of PE markedly reduces the quality of life and has a significant impact on the prognosis of those diagnosed with both lung cancer and PE. As a result, timely diagnosis and intervention are of paramount importance. The presence of PE markedly reduces the quality of life and has a significant impact on the prognosis of those diagnosed with both lung cancer and PE. As a result, timely diagnosis and intervention are of paramount importance.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) conducted a review in Lung cancer and pulmonary embolism. Lung cancer and anti-tumor therapies was evaluated. Pulmonary embolism is a frequent and serious complication in patients with lung cancer that significantly worsens prognosis and complicates anti-tumor therapy due to competing risks of thrombosis and hemorrhage.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: